Inflammatory activity levels on patients with anti-TNF therapy: most important factors and a decision tree model based on REGISPONSER and RESPONDIA registries.

Journal: Therapeutic advances in musculoskeletal disease
Published Date:

Abstract

BACKGROUND: The effectiveness of anti-tumour necrosis factor (TNF) therapy in spondyloarthritis is traditionally associated with factors such as age, obesity and disease subtypes. However, less-explored aspects, such as mental health, socioeconomic status and work type may also play a crucial role in determining inflammatory activity and therapeutic response.

Authors

  • David Castro Corredor
    Rheumatology Department, Hospital General Universitario Ciudad Real, Obispo Rafael Torija Street, Ciudad Real 13005, Spain.
  • Luis Ángel Calvo Pascual
    Department of Quantitative Methods, ICADE, Universidad Pontificia de Comillas, Madrid, Spain.
  • Eduardo Collantes-Estévez
    Rheumatology Service (L.P.-S., A.M.P.-T., M.A.A.-Z., M.L.-T., M.C.A.-A., I.A.-d.l.R., N.B., A.E.-C., E.C.-E., C.L.-P.), Reina Sofia Hospital/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/University of Cordoba, Spain.
  • Clementina López-Medina
    Rheumatology Department, Reina Sofia Hospital, Cordoba / IMIBIC / University of Cordoba, Cordoba, Spain.

Keywords

No keywords available for this article.